Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies.
Oana C DanciuMatthias HoldhoffRichard A PetersonJames H FischerLi C LiuHeng WangNeeta K VenepalliRozina ChowdheryM Kelly NicholasMeredith J RussellTimothy M FanPaul J HergenrotherTheodore M TarasowArkadiusz Z DudekPublished in: British journal of cancer (2022)
Clinical Trials.gov: NCT02355535.